In KEGG gene sets, GSEA results show that AP2M1 is mainly enriched in glycosphingolipid biosynthetic ganglion series, Parkinson’s disease, Alzheimer’s disease, β-Alanine metabolism, and axonal guidance mechanism. The gene discussed is AP2M1; the disease is Parkinson disease.